Role and Outcome of Endovascular Revascularization of Chronic Limb Ischaemia

Role and Outcome of Endovascular Revacularization of Chronic Limb Threatening Ischaemia in Patients With Chronic Kidney Diseases

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05643378

Enrollment

100

Registered

2022-12-08

Start date

2022-12-01

Completion date

2023-10-01

Last updated

2022-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Limb Ischemia, Critical

Brief summary

identify the safety and efficacy of percutaneous transluminal angioplasty in critical limb ischaemia patients with chronic kidney dieases

Detailed description

patients with chronic kidney diseases are at higher risk of developing peripheral artery diseases needing revascularization of diseased arteries via endovascular transluminal angioplasty

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Inclusion criteria

* all patients with chronic kidney diseases on medical treatment or on dialysis and have critical limb ischaemia

Exclusion criteria

* patients with acute renal failure and lower limb ischaemia. * chronic kidney diseased patients underwent previous intervention or surgery for lower limb ischaemia. * patients presented with acute limb ischaemia

Design outcomes

Primary

Measure	Time frame	Description
one year evaluation for maintaining vessel patency without restenosis or need for re intervention in 100 participants	baseline	all patients will be scheduled for follow up visits every 3 months for 1 year assessing primary patency and major adverse limb events. duplex scanning will be performed for all patients

Outcome results